Whetstone Capital Advisors LLC Makes New $7.72 Million Investment in Health Catalyst, Inc. $HCAT

Key Points

• Whetstone Capital Advisors LLC invested approximately $7.72 million to acquire 1,705,072 shares of Health Catalyst, Inc., making it the firm's 10th largest holding.
• Several hedge funds have also increased their stakes in Health Catalyst, with institutional investors owning about 85% of the stock.
• The stock has received mixed ratings from analysts, with target prices decreasing recently, reflecting a consensus average target of $6.18 and a majority rating of "Hold."

Whetstone Capital Advisors LLC bought a new stake in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 1,705,072 shares of the company's stock, valued at approximately $7,724,000. Health Catalyst comprises approximately 3.4% of Whetstone Capital Advisors LLC's portfolio, making the stock its 10th largest position. Whetstone Capital Advisors LLC owned about 2.43% of Health Catalyst as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. SG Americas Securities LLC lifted its stake in shares of Health Catalyst by 195.2% in the 1st quarter. SG Americas Securities LLC now owns 80,825 shares of the company's stock valued at $366,000 after acquiring an additional 53,443 shares during the last quarter. BNP Paribas Financial Markets bought a new stake in shares of Health Catalyst in the 4th quarter valued at about $735,000. Wells Fargo & Company MN lifted its stake in shares of Health Catalyst by 27.3% in the 4th quarter. Wells Fargo & Company MN now owns 39,355 shares of the company's stock valued at $278,000 after acquiring an additional 8,451 shares during the last quarter. Two Sigma Investments LP bought a new stake in shares of Health Catalyst in the 4th quarter valued at about $496,000. Finally, Northern Trust Corp lifted its stake in shares of Health Catalyst by 8.5% in the 4th quarter. Northern Trust Corp now owns 526,607 shares of the company's stock valued at $3,723,000 after acquiring an additional 41,298 shares during the last quarter. Institutional investors own 85.00% of the company's stock.

Health Catalyst Stock Up 0.5%

Shares of HCAT stock traded up $0.02 during midday trading on Tuesday, reaching $3.36. 227,699 shares of the stock were exchanged, compared to its average volume of 713,296. Health Catalyst, Inc. has a 1 year low of $2.52 and a 1 year high of $9.24. The company's 50 day moving average is $3.64 and its two-hundred day moving average is $4.04. The company has a current ratio of 1.83, a quick ratio of 1.83 and a debt-to-equity ratio of 0.44. The firm has a market cap of $236.25 million, a PE ratio of -2.23 and a beta of 1.46.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the company. Evercore ISI lowered their target price on Health Catalyst from $5.00 to $4.00 and set an "in-line" rating for the company in a research note on Wednesday, July 9th. BTIG Research lowered Health Catalyst from a "buy" rating to a "neutral" rating in a research report on Tuesday, June 17th. Wells Fargo & Company lowered their price target on Health Catalyst from $10.00 to $6.00 and set an "overweight" rating for the company in a research report on Monday, August 11th. Cantor Fitzgerald reaffirmed a "neutral" rating and set a $4.00 price target (down previously from $9.00) on shares of Health Catalyst in a research report on Friday, August 8th. Finally, Canaccord Genuity Group lowered their price target on Health Catalyst from $10.00 to $9.00 and set a "buy" rating for the company in a research report on Thursday, May 8th. Five research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $6.18.

Health Catalyst Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.